Artificial Intelligence for Highly Myopic Cataract
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorShanghai High Myopia Study Group
About this trial
This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- newly-invented AI model
Treatment groups
500,000 Participants
are divided into 4 treatment groupsSponsors and collaborators
Shanghai High Myopia Study Group
Lead sponsor
Eye and ENT Hospital of Fudan University
Collaborator
Source ClinicalTrials.gov